MeSH term
Frequency | Condition_Probility | Chromosome Mapping | 8 | 0.0 |
*Chromosomes, Human, Pair 1 | 3 | 0.0 |
Female | 24 | 0.0 |
Humans | 49 | 0.0 |
Male | 24 | 0.0 |
Pedigree | 14 | 0.0 |
Recurrence | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 31 | 0.0 |
Animals | 23 | 0.0 |
Child | 8 | 0.0 |
*Drosophila Proteins | 9 | 0.0 |
Endothelin-3/genetics | 8 | 61.0 |
Hirschsprung Disease/complications/*genetics | 2 | 66.0 |
Infant | 7 | 0.0 |
Mice | 17 | 0.0 |
Mice, Knockout | 2 | 0.0 |
*Mutation | 16 | 0.0 |
Nerve Growth Factors/genetics | 4 | 12.0 |
Proto-Oncogene Proteins/*genetics | 6 | 0.0 |
Receptor Protein-Tyrosine Kinases/*genetics | 8 | 2.0 |
Receptor, Endothelin B | 17 | 28.0 |
Receptors, Endothelin/genetics | 10 | 66.0 |
Alleles | 3 | 0.0 |
Genetic Markers | 3 | 0.0 |
Hirschsprung Disease/*genetics | 23 | 31.0 |
Models, Genetic | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Disease Models, Animal | 3 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Mice, Inbred Strains | 2 | 0.0 |
Mutation | 8 | 0.0 |
Phenotype | 12 | 0.0 |
Receptors, Endothelin/*genetics | 10 | 37.0 |
Cell Line | 5 | 0.0 |
Mice, Inbred C57BL | 4 | 0.0 |
Amino Acid Sequence | 8 | 0.0 |
CHO Cells | 2 | 0.0 |
Calcium/metabolism | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Molecular Sequence Data | 15 | 0.0 |
Protein Binding | 3 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Signal Transduction | 4 | 0.0 |
Transfection | 2 | 0.0 |
English Abstract | 8 | 0.0 |
Case-Control Studies | 3 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
*Nerve Growth Factors | 3 | 1.0 |
Polymorphism, Single-Stranded Conformational | 6 | 0.0 |
Proto-Oncogene Proteins/genetics | 4 | 0.0 |
Receptor Protein-Tyrosine Kinases/genetics | 6 | 4.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Crosses, Genetic | 2 | 0.0 |
Genes, Dominant | 2 | 0.0 |
Mice, Inbred C3H | 2 | 0.0 |
Adult | 4 | 0.0 |
Point Mutation | 4 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Diagnosis, Differential | 2 | 0.0 |
In Situ Hybridization | 3 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Trans-Activation (Genetics) | 3 | 0.0 |
Amino Acid Substitution | 3 | 0.0 |
Child, Preschool | 6 | 0.0 |
Consanguinity | 2 | 0.0 |
Infant, Newborn | 5 | 0.0 |
Syndrome | 4 | 0.0 |
Variation (Genetics) | 4 | 0.0 |
Endothelin-3/*genetics | 4 | 66.0 |
Base Sequence | 11 | 0.0 |
DNA Mutational Analysis | 6 | 0.0 |
Nerve Tissue Proteins/*genetics | 2 | 0.0 |
Reproducibility of Results | 2 | 0.0 |
Sequence Deletion | 2 | 0.0 |
DNA-Binding Proteins/chemistry/*genetics | 2 | 2.0 |
Genes, Dominant/genetics | 2 | 1.0 |
Heterozygote | 4 | 0.0 |
High Mobility Group Proteins/chemistry/*genetics | 2 | 15.0 |
Cloning, Molecular | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 3 | 0.0 |
Waardenburg's Syndrome/*genetics | 3 | 7.0 |
Family Health | 2 | 0.0 |
Adolescent | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Multigene Family | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Cell Division | 2 | 0.0 |
RNA, Messenger | 2 | 0.0 |
Frameshift Mutation | 2 | 0.0 |
Exons | 4 | 0.0 |
Rats | 3 | 0.0 |
Waardenburg's Syndrome/genetics | 2 | 9.0 |
DNA/genetics | 2 | 0.0 |
Endothelins/*genetics | 5 | 41.0 |
Homozygote | 3 | 0.0 |
*Chromosome Mapping | 3 | 0.0 |
Genotype | 3 | 0.0 |
Hirschsprung Disease/*genetics/physiopathology | 2 | 66.0 |
*Genes, Lethal | 2 | 7.0 |
*Chromosomes, Human, Pair 20 | 2 | 1.0 |
Transcription Factors/*genetics | 2 | 0.0 |
High Mobility Group Proteins/*genetics | 2 | 2.0 |
